We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Sam Alworth is the CEO of AcuraStem Inc., a biotechnology startup working on cures and improved diagnoses for Amyotrophic Lateral Sclerosis, Frontotemporal Dementia and Alzheimer's Disease. AcuraStem utilizes advanced stem cell technology and machine learning to study diseases of the central nervous system using living neurons from current patients – a virtual nerve biopsy. He strongly believes that this approach will soon deliver new insights into the clinic, and new therapies for challenging CNS disorders.
Sam has over 15 years’ experience in entrepreneurship, product management, business development and R&D in the life sciences, and has raised over $19M from investors and nondilutive government R&D funding. He has the bioinformatics and machine learning expertise required to drive the new experiments using human cell models, and a proven ability to manage large international, multidisciplinary scientific projects. Sam has several U.S. patents and scientific journal publications.
This speaker's sessions: